Smith & Nephew Share Price | |
---|---|
Price | 974.80 |
Bid | 933.00 |
Ask | 1,044.00 |
Change | 0.00 (0.00%) |
Volume | 0 |
Open | 0.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 974.80 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 874.33m |
Market Capitalisation | £8.52b |
Market Size | 2,000 |
52 Week High | 1,316.00 |
52 Week High Date | 02-May-2023 |
52 Week Low | 887.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 0 |
---|---|
Vol. Sold | 0 |
Sold Value | £N/A |
Vol. Bought | 0 |
Bought Value | £N/A |
PE Ratio | 41.09635 |
Earnings | 23.71987 |
Dividend | 30.27 |
Yield | 3.105% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
22-Apr-24 | 18:08:55 | 972.956 | 17,675 | Unknown* | 977.60 | 977.80 | 171.97k | O Ordinary Was reported as OTC |
22-Apr-24 | 18:08:09 | 973.11 | 7,610 | Unknown* | 977.60 | 977.80 | 74.05k | O Ordinary Was reported as OTC |
22-Apr-24 | 18:07:27 | 972.874 | 34,064 | Unknown* | 977.60 | 977.80 | 331.40k | O Ordinary Was reported as OTC |
22-Apr-24 | 18:06:26 | 974.80 | 135 | Unknown* | 977.60 | 977.80 | 1,316 | O Ordinary Was reported as OTC |
22-Apr-24 | 18:05:04 | 974.784 | 2,257 | Unknown* | 977.60 | 977.80 | 22.00k | O Ordinary Was reported as OTC |
22-Apr-24 | 18:04:13 | 972.08 | 347 | Unknown* | 977.60 | 977.80 | 3,373 | O Ordinary Was reported as OTC |
22-Apr-24 | 18:04:13 | 974.80 | 25,701 | Unknown* | 977.60 | 977.80 | 250.53k | O Ordinary Was reported as OTC |
22-Apr-24 | 18:04:13 | 974.80 | 26,351 | Unknown* | 977.60 | 977.80 | 256.87k | O Ordinary Was reported as OTC |
22-Apr-24 | 17:46:38 | 976.698 | 524 | Unknown* | 977.60 | 977.80 | 5,118 | O Ordinary Was reported as OTC |
22-Apr-24 | 17:46:38 | 976.18 | 2,245 | Unknown* | 977.60 | 977.80 | 21.92k | O Ordinary Was reported as OTC |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
17-Jan-24 | 09-Jan-24 | Buy | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 23.19 | USD | 408 | 107,222 |
14-Nov-23 | 13-Nov-23 | Sell | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 1,001.09 | GBX | 1,961 | 106,814 |
14-Nov-23 | 13-Nov-23 | Transfer From | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 0.00 | 4,788 | 106,814 | |
10-Nov-23 | 10-Nov-23 | Buy | Jeremy (Jez) Maiden held the position of Independent Non-Executive Director at the time of this trade.Jeremy (Jez) Maiden | 1,007.75 | GBX | 1,000 | 1,000 |
10-Nov-23 | 08-Nov-23 | Sell | Deepak Nath held the position of CEO at the time of this trade.Deepak Nath | 987.80 | GBX | 1,771 | 103,987 |
Smith+Nephew is a portfolio medical device company focused on the repair, regeneration and replacement of soft and hard tissue.